Top Priority Sector:  disaster_preparedness_emergency_response Inovio Pharmaceuticals, Inc. expanded its existing license agreement on Nov. 14 with the University of Pennsylvania (UPenn), adding worldwide rights to technology and intellectual property for novel synthetic vaccines against potential biodefense pathogens, cancer, and infectious diseases. The technologies were developed by UPenn Professor David Weiner…